Reply discusses associations of MEFV curve concavity with COPD incidence and respiratory symptoms in longitudinal study.
Extract Reply to F. Mochizuki and colleagues: We thank F. Mochizuki and colleagues for their interest in our recent Tasmanian Longitudinal Health Study (TAHS) publication on concavity of the maximal expiratory flow–volume (MEFV) curve and its association with incidence of COPD and respiratory symptoms [1].
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: